Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) shot up 0.5% on Friday . The stock traded as high as €41.80 ($44.95) and last traded at €41.80 ($44.95). 100 shares were traded during mid-day trading, a decline of 95% from the average session volume of 1,927 shares. The stock had previously closed at €41.60 ($44.73).
Biotest Aktiengesellschaft Stock Performance
The firm has a market cap of $827.22 million, a P/E ratio of 18.25 and a beta of 0.27. The company has a current ratio of 5.00, a quick ratio of 1.66 and a debt-to-equity ratio of 151.29. The company’s 50-day moving average is €42.04 and its two-hundred day moving average is €42.28.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Recommended Stories
- Five stocks we like better than Biotest Aktiengesellschaft
- Upcoming IPO Stock Lockup Period, Explained
- Appleās Earnings Show Investors Its Strength and Its Weakness
- There Are Different Types of Stock To Invest In
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.